Here, we identified three cases of PTCL-NOS that uniformly expressed T-cell specific antigens (CD2 and CD3) and the B marker CD20 (CD20+ PTCL-NOS). This evidence concerns the gene CD2 and mature T-cell and NK-cell non-Hodgkin lymphoma.